Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombination hotspot in NF1 microdeletion patients.

C López-Correa1, M Dorschner, H Brems

  • 1Center for Human Genetics, Catholic University Leuven, Herestraat 49, B-3000 Leuven, Belgium.

Human Molecular Genetics
|July 7, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation of Evidence-Based Implant Dentistry Into Daily Practice.

The Journal of oral implantology·2026
Same author

Serum Fructosamine as a Presurgical Marker to Assess Glycemic Control.

The Journal of oral implantology·2025
Same author

Patient Perspectives on Immediate Zirconia Implant Therapy: Results from a Long-term Multicenter European Study.

The Journal of oral implantology·2025
Same author

Additional genetic variants in cardiomyopathy patients with the pathogenic PLN p.(Arg14del) founder variant.

International journal of cardiology·2025
Same author

Ceramic Implant Rehabilitation: Consensus Statements from Joint Congress for Ceramic Implantology: Consensus Statements on Ceramic Implant.

The Journal of oral implantology·2024
Same author

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Neurofibromatosis type 1 (NF1) microdeletions, often maternal, cause early onset and numerous dermal neurofibromas. A new assay identifies a specific hotspot for these NF1 microdeletions, aiding diagnosis.

Area of Science:

  • Genetics
  • Molecular Biology
  • Human Disease Genetics

Background:

  • Neurofibromatosis type 1 (NF1) is a genetic disorder characterized by tumor formation.
  • NF1 microdeletions are associated with severe phenotypes, including early onset and a high burden of dermal neurofibromas.
  • These microdeletions typically arise from maternal unequal crossing over between NF1REP paralogous sequences flanking the NF1 gene.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying NF1 microdeletions.
  • To identify the specific recombination events and hotspots involved in NF1 microdeletion formation.
  • To develop a diagnostic assay for identifying patients with NF1 microdeletions originating from a specific hotspot.

Main Methods:

  • Breakpoint mapping and sequencing in NF1 microdeletion patients.

Related Experiment Videos

  • Design of primers to amplify a 3.4 kb deletion junction fragment.
  • Screening of 54 unrelated NF1 microdeletion patients using the developed assay.

    • Main Results:

    • The deletion-junction assay successfully amplified a fragment from 25 out of 54 patients.
    • Sequence analysis revealed that all 25 recombination events occurred within a 2 kb hotspot in the NF1REPs.
    • Two recombination events showed evidence of gene conversion, and a chi-like sequence was identified as a potential recombination-prone motif.

    Conclusions:

    • A specific recombination hotspot within NF1REPs is frequently involved in NF1 microdeletions.
    • The developed deletion-junction assay can prospectively identify patients with NF1 microdeletions originating from this hotspot.
    • This assay will aid in genotype-phenotype correlation studies and diagnostic evaluations for NF1.